Press Releases :: ContraFect Corporation (CFRX)

Press Releases

Investors & Media

ContraFect to Present at 28th Annual Piper Jaffray Healthcare Conference

November 23, 2016

ContraFect Awarded $2.1 Million PRMRP Grant to Support Development of CF-301

November 17, 2016

ContraFect Announces Expanded Research Collaboration with The Rockefeller University to Identify Lysin Therapeutics Targeting Gram-negative Bacteria

November 14, 2016

ContraFect to Present at The Lysin Meeting

November 10, 2016

ContraFect Reports Third Quarter 2016 Financial Results and Provides Business Update

November 9, 2016

ContraFect Announces Organizational Changes

September 16, 2016

ContraFect Announces Second Quarter 2016 Results

August 9, 2016

ContraFect Receives Designation as a Small and Medium Enterprise by the European Medicines Agency

August 4, 2016

ContraFect Corporation Prices $35 Million Public Offering of Common Stock and Warrants

July 22, 2016

ContraFect Corporation Names Steven C. Gilman, PhD Chief Executive Officer

July 21, 2016